Cambridge, MA, United States of America

Rajendra K Pandey

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Alnylam Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc.. Active years: 2011-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajendra K Pandey. Retrieved from https://idiyas.com/inventor/rajendra-k-pandey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 62(Granted Patents)


Location History:

  • South Grafton, MA (US) (2011)
  • Framingham, MA (US) (2011 - 2015)
  • Cambridge, MA (US) (2013 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Rajendra K Pandey

Introduction

Rajendra K Pandey is a notable inventor based in Cambridge, MA, with a significant contribution to the field of biotechnology. He holds a total of six patents, showcasing his innovative approach to solving complex problems in medical science.

Latest Patents

Among his latest patents, one focuses on "Chemical modifications of monomers and oligonucleotides with cycloaddition." This invention features compounds that relate to processes for conjugating ligands to oligonucleotides. It also addresses methods for treating various disorders and diseases, including viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies, and immunosuppression. Another significant patent is for "Stabilized immunomodulatory oligonucleotides." This invention provides immunostimulatory oligonucleotides that contain at least one CpG dinucleotide and a secondary structure at either the 5'- or 3'-end. The findings indicate that 5'-terminal secondary structures significantly affect immunostimulatory activity more than those at the 3'-end. Additionally, it offers methods for modulating the immunostimulatory activity of CpG-containing nucleic acids.

Career Highlights

Rajendra K Pandey has worked with prominent companies in the biotechnology sector, including Alnylam Pharmaceuticals, Inc. and Idera Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in therapeutic solutions and innovative drug development.

Collaborations

Throughout his career, Rajendra has collaborated with esteemed colleagues such as Muthiah Manoharan and Kallanthottathil G Rajeev. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Rajendra K Pandey's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of various diseases and disorders, showcasing the importance of innovation in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…